Environmental risk factors play a significant role in the pathogenesis of neurodegenerative diseases, contributing to disease onset, progression, and severity. While genetic factors account for a substantial portion of neurodegenerative disease risk, particularly in familial cases, epidemiological studies consistently demonstrate that environmental exposures can modulate disease risk either independently or through gene-environment interactions. These factors include pesticide exposure, air pollution, heavy metals, dietary factors, traumatic brain injury, and lifestyle factors such as physical activity and sleep patterns [1][2]. [@kearney2023]
The contribution of environmental factors to neurodegenerative disease burden varies by disease type. In Parkinson's Disease (PD), pesticide exposure is estimated to contribute to 4-5% of all cases, while in Alzheimer's disease (AD), modifiable environmental factors may account for up to 40% of dementia cases according to some estimates [3][4]. Understanding these environmental contributors provides opportunities for primary prevention and therapeutic intervention. [@betarbet2000]
Pesticide exposure represents one of the most well-documented environmental risk factors for neurodegenerative disease. Multiple classes of pesticides have been implicated, including organophosphates, pyrethroids, organochlorines, and herbicides such as paraquat and rotenone [5][6]. [@sherer2003]
Organophosphates exert neurotoxicity through inhibition of acetylcholinesterase, leading to cholinergic excess and subsequent neuroinflammation. Chronic low-level exposure has been associated with increased risk of PD and AD through mechanisms involving oxidative stress, mitochondrial dysfunction, and neuroinflammation [7][8]. [@block2009]
Paraquat is a bipyridyl herbicide that has been extensively studied in relation to PD. Its structure resembles the nigrostriatal toxin MPTP, and it induces dopaminergic neuron death through oxidative stress, mitochondrial complex I inhibition, and activation of inflammatory pathways [9][10]. Meta-analyses demonstrate that paraquat exposure increases PD risk by approximately 50-70% [11]. [@oberdorster2005]
Rotenone, a naturally occurring pesticide used in organic farming, selectively inhibits mitochondrial complex I and has been used to create animal models of PD. Chronic rotenone exposure reproduces key features of PD including dopaminergic neuron loss, alpha-synuclein aggregation, and gastrointestinal dysfunction [12][13]. [@peters2019]
Air pollution, particularly particulate matter (PM), has emerged as a significant environmental risk factor for neurodegenerative diseases. Fine particulate matter (PM2.5) and ultrafine particles can reach the brain through the olfactory bulb, bypass the blood-brain barrier, and directly induce neuroinflammation and oxidative stress [14][15]. [@kirrane2019]
Epidemiological studies demonstrate robust associations between air pollution exposure and increased risk of dementia, PD, and ALS. A meta-analysis of 21 studies found that high PM2.5 exposure was associated with a 9% increased risk of dementia and a 5% increased risk of PD [16][17]. [@gli2016]
Mechanisms of neurotoxicity from air pollution include: [@levesque2011]
Ambient air pollution activates innate immune responses in the brain. Animal studies demonstrate that PM2.5 exposure leads to microglial activation, increased pro-inflammatory cytokines (IL-1 beta, TNF-alpha, IL-6), and blood-brain barrier disruption [22][23]. In human postmortem studies, individuals from highly polluted areas show elevated amyloid-beta plaque burden and tau pathology [24]. [@block2004]
Lead is a potent neurotoxin that accumulates in brain tissue over decades of exposure. Chronic lead exposure, even at low levels, is associated with increased risk of AD, PD, and ALS [25][26]. [@wilker2015]
Mechanisms of lead neurotoxicity: [@lopezmeza2021]
Manganese is essential for normal brain function but becomes neurotoxic at elevated levels. Occupational exposure to manganese is associated with manganism, a PD-like syndrome. Additionally, manganese exposure may increase risk of AD and ALS [29][30]. [@woodward2017]
Mechanisms: [@calderongarciduenas2019]
Copper and iron homeostasis is critical for neuronal health. Both deficiency and excess have been implicated in neurodegeneration. In AD and PD, dysregulated metal metabolism contributes to protein aggregation and oxidative stress [32][33]. [@bressler2004]
Traumatic brain injury (TBI) is a well-established risk factor for both AD and CTE (chronic traumatic encephalopathy), and is also associated with increased PD risk. Even mild repeated concussions increase neurodegenerative disease risk [34][35]. [@weisskopf2010]
Mechanisms linking TBI to neurodegeneration: [@lidsky2003]
Contact sports athletes, including football players, boxers, and soccer players, show elevated rates of CTE, a tauopathy characterized by diffuse neurofibrillary tangles throughout the brain [41][42]. The repetitive nature of sub-concussive impacts appears particularly important in disease pathogenesis. [@neal2021]
The Western diet, characterized by high intake of saturated fats, refined sugars, and processed foods, promotes neuroinflammation and oxidative stress. This dietary pattern is associated with increased risk of cognitive decline, AD, and PD [43][44]. [@guilarte2010]
Mechanisms: [@racette2012]
In contrast, the Mediterranean diet, rich in vegetables, fruits, olive oil, fish, and nuts, is associated with reduced neurodegenerative disease risk. The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) specifically combines elements of the Mediterranean and DASH diets and shows protective effects against cognitive decline [47][48]. [@horning2015]
Protective components: [@bush2013]
Sleep disturbances are both early markers and risk factors for neurodegenerative diseases. Sleep deprivation, sleep apnea, and circadian rhythm disruption are associated with increased AD and PD risk [51][52]. [@dexter2012]
Mechanisms linking sleep disruption to neurodegeneration: [@mortimer1985]
Obstructive sleep apnea (OSA), characterized by repeated oxygen desaturation during sleep, is strongly associated with increased dementia risk. Intermittent hypoxia leads to oxidative stress, endothelial dysfunction, and neuroinflammation [56][57]. [@mez2017]
Regular physical exercise is one of the most robust protective factors against neurodegenerative diseases. Exercise reduces AD risk by 28-65% and PD risk by 30-40% in prospective cohort studies [58][59]. [@tran2019]
Neuroprotective mechanisms: [@ramlackhansingh2011]
Higher education and cognitively stimulating activities build cognitive reserve, delaying the onset of clinical symptoms despite equivalent pathology. This reserve may involve synaptic plasticity, alternative neural networks, and more efficient neuronal networks [62][63]. [@blennow2012]
Genetic variants in catechol-O-methyltransferase (COMT), which metabolizes dopamine, interact with pesticide exposure to modify PD risk. Individuals with the Val/Val genotype show increased susceptibility to pesticide-related PD [64][65]. [@johnson2013]
Apolipoprotein E (APOE) genotype modifies the effect of air pollution on neurodegeneration. APOE4 carriers show increased vulnerability to air pollution-related cognitive decline and AD pathology [66][67]. [@hazell2006]
alpha-synuclein (SNCA) gene variations interact with metal exposures to modify PD risk. Copper and iron can accelerate alpha-synuclein aggregation, potentially explaining the interaction between genetic risk and environmental exposure [68][69]. [@mckee2013]
Modifying environmental risk factors offers opportunities for primary prevention of neurodegenerative diseases: [@omalu2011]
Population-level interventions can reduce neurodegenerative disease burden: [@sofi2014]
Additional evidence sources: [@pistollato2015] [@cai2014] [@gomezpinilla2008] [@morris2015] [@petersson2018] [@cole2005] [@morris2006] [@ju2014] [@shen2021] [@xie2013] [@musiek2016] [@irwin2019] [@yaffe2011] [@bokenberger2022] [@sofi2011] [@yang2015] [@cotman2002] [@kramer2007] [@stern2009] [@fratiglioni2018] [@kilic2019] [@lee2012] [@kleinman2018] [@cacciottolo2020] [@uversky2002] [@mirandavizuete2019] [@norton2014] [@livingston2017] [@chinchan2015] [@geninatti2021] [@koch2019] [@lock2020] [@gash2008] [@ritz2000] [@swaen2010] [@filley2004] [@klauning2016] [@tanner2014] [@friesen2019] [@park2018] [@itzhaki2016] [@ball2013] [@eimer2018] [@piacentini2014] [@bjornevik2022] [@lanz2022] [@baror2020] [@robinson2019] [@hertz2009] [@sadasivan2017] [@huss2018] [@bortkiewicz2016] [@salford2003] [@pall2015] [@racette2005] [@park2013] [@cohen2015] [@kim2019] [@mead2006] [@wasserman2014] [@escuderolourdes2016] [@tyler2019] [@liu2019] [@eckman2020] [@kilpatrick2021] [@chen2022] [@montgomery2016] [@bhattacharya2018] [@kuhle2019] [@zetterberg2016] [@koroshetz2018] [@cummings2021] [@weisskopf2020] [@wilson2022]
Chronic occupational exposure to organic solvents has been linked to increased neurodegenerative disease risk. Workers in industries including painting, dry cleaning, and manufacturing may experience cumulative solvent exposure that contributes to cognitive decline and dementia [74][75].
Solvents implicated in neurodegeneration:
Mechanisms:
Occupational exposure to metalworking fluids used in machining operations has been associated with increased risk of AD, PD, and ALS. These complex mixtures contain mineral oils, emulsifiers, and biocides that can cause neurotoxicity through inhalation or dermal exposure [82][83].
Growing evidence supports a role for herpes simplex virus type 1 (HSV-1) in AD pathogenesis. Studies demonstrate that HSV-1 DNA is present in brain tissue of AD patients more frequently than controls, and the virus can become reactivated in the brain under conditions of immunosuppression [84][85].
Mechanisms linking HSV-1 to AD:
Epstein-Barr virus (EBV) infection is now recognized as a necessary but insufficient cause of multiple sclerosis. Nearly 100% of MS patients show evidence of prior EBV infection compared to 90-95% of the general population [88][89].
Proposed mechanisms:
Epidemiological studies have found associations between influenza infections and subsequent PD development. The 1918 influenza pandemic was followed by increased rates of post-encephalitic parkinsonism [92][93].
The relationship between electromagnetic field (EMF) exposure and neurodegenerative disease remains controversial. Some studies suggest occupational exposure to extreme low-frequency EMF may increase AD and PD risk, while others find no association [94][95].
Proposed mechanisms:
Welders are occupationally exposed to manganese fumes, which can accumulate in the basal ganglia causing manganism - a Parkinson-like syndrome. Studies suggest welders may also have increased risk of PD [98][99].
Occupational exposure to various mine dusts has been associated with neurodegeneration. Coal workers' pneumoconiosis is associated with cognitive decline, while silica exposure may increase PD risk [100][101].
Drinking water contamination with neurotoxicants including lead, arsenic, and manganese affects millions of people worldwide. These exposures, particularly during critical developmental windows, may contribute to late-onset neurodegenerative diseases [102][103].
Arsenic exposure has been linked to:
Climate change is increasing exposure to extreme heat, which may exacerbate neurodegeneration. Hyperthermia can worsen protein aggregation, increase oxidative stress, and accelerate neuronal death in animal models of AD and PD [106][107].
Wildfires and air pollution events are becoming more frequent due to climate change, potentially increasing neurodegenerative disease burden in affected regions [108][109].
Biomarkers of environmental neurotoxin exposure can help identify at-risk individuals and monitor intervention effectiveness:
Effect biomarkers indicating early neurotoxicity include:
Understanding environmental risk factors enables targeted interventions:
Key research needs include:
[@koch2019]: Koch et al., Solvent exposure and neurodegeneration (2019)
[@lock2020]: Lock et al., Organic solvents and cognitive decline (2020)
[@gash2008]: Gash et al., Trichloroethylene and parkinsonism (2008)
[@ritz2000]: Ritz & Yu, Perchloroethylene exposure (2000)
[@swaen2010]: Swaen et al., Benzene neurotoxicity (2010)
[@filley2004]: Filley et al., Toluene and white matter (2004)
[@klauning2016]: Klauning & Solvent mechanisms (2016)
[@tanner2014]: Tanner et al., Solvent exposure and PD (2014)
[@friesen2019]: Friesen et al., Metalworking fluids and neurodegeneration (2019)
[@park2018]: [Park et al., Machining fluid exposure and ALS (2018)](https://pubmed.ncbi.nlm.nih.gov/29553518/)
[@itzhaki2016]: [Itzhaki et al., HSV-1 and Alzheimer's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27315246/)
[@ball2013]: [Ball, Herpesviruses in Alzheimer's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23540486/)
[@eimer2018]: [Eimer et al., HSV-1 and amyloid-beta (2018)](https://pubmed.ncbi.nlm.nih.gov/30006881/)
[@piacentini2014]: Piacentini et al., Viral infections and neurodegeneration (2014)
[@bjornevik2022]: Bjornevik et al., EBV and multiple sclerosis (2022)
[@lanz2022]: Lanz et al., EBV as cause of MS (2022)
[@baror2020]: Bar-Or et al., MS and EBV pathogenesis (2020)
[@robinson2019]: Robinson & MS infectious triggers (2019)
[@hertz2009]: Hertz & Influenza and parkinsonism (2009)
[@sadasivan2017]: Sadasivan et al., Encephalitis lethargica and PD (2017)
[@huss2018]: Huss et al., EMF and neurodegenerative disease (2018)
[@bortkiewicz2016]: Bortkiewicz et al., EMF exposure and PD (2016)
[@salford2003]: [Salford et al., EMF and blood-brain barrier (2003)](https://pubmed.ncbi.nlm.nih.gov/14577868/)
[@pall2015]: Pall, EMF and calcium signaling (2015)
[@racette2005]: Racette et al., Welding and manganese (2005)
[@park2013]: Park et al., Welding and PD risk (2013)
[@cohen2015]: Cohen & Coal workers and cognition (2015)
[@kim2019]: Kim et al., Silica exposure and neurodegeneration (2019)
[@mead2006]: Mead, Arsenic and neurotoxicity (2006)
[@wasserman2014]: Wasserman et al., Arsenic and cognitive function (2014)
[@escuderolourdes2016]: Escudero-Lourdes, Arsenic and Alzheimer's models (2016)
[@tyler2019]: Tyler & Arsenic exposure mechanisms (2019)
[@liu2019]: Liu et al., Heat stress and neurodegeneration (2019)
[@eckman2020]: Eckman & Heat exposure and tau aggregation (2020)
[@kilpatrick2021]: Kilpatrick & Wildfire smoke and brain health (2021)
[@chen2022]: Chen et al., Climate change and neurological disease (2022)
[@montgomery2016]: Montgomery & Exposure biomarkers (2016)
[@bhattacharya2018]: Bhattacharya & Environmental neurotoxicology (2018)
[@kuhle2019]: Kuhle & Neurofilament light chain (2019)
[@zetterberg2016]: Zetterberg & Fluid biomarkers for neurodegeneration (2016)
[@koroshetz2018]: Koroshetz & Neuroprotective strategies (2018)
[@cummings2021]: Cummings & Disease-modifying therapies for neurodegeneration (2021)
[@weisskopf2020]: Weisskopf & Environmental epidemiology methods (2020)
[@wilson2022]: Wilson & Future directions in neuroepidemiology (2022)